Document:

Form of Change of Control Severance Benefits Agreement.

 Exhibit 10.13 
 CHANGE OF CONTROL SEVERANCE BENEFITS AGREEMENT 
 THIS FORM
OF CHANGE OF CONTROL SEVERANCE BENEFITS AGREEMENT MAY BE ENTERED INTO
BETWEEN MEDIVATION, INC. AND EACH OF ITS OFFICERS (“OFFICER”), SENIOR VICE
PRESIDENTS (“SVP”), VICE PRESIDENTS (“VP”) AND SENIOR DIRECTORS (“SD”). THIS AGREEMENT
PROVIDES FOR DIFFERENT LEVELS OF BENEFITS FOR OFFICER AND SVPS VERSUS
VPS AND SDS. WHERE THE BENEFIT LEVELS DIFFER AMONG CLASSIFICATIONS, THE
BENEFIT LEVELS FOR EACH CLASSIFICATION ARE INDICATED IN THIS FORM OF
AGREEMENT IN BRACKETED TEXT. 
 This CHANGE
OF CONTROL SEVERANCE BENEFITS AGREEMENT (this “Agreement”) is made as of the
             th day of                         ,
2         by and between Medivation, Inc., a Delaware Corporation, and
                                 [Officer/SVP:
(“Executive”)][VP/SD: (“Employee”)]. 
 Background 
 WHEREAS, this Agreement provides the terms and conditions for the severance benefits that the Company will provide to [Executive/Employee] due to
[Executive’s/Employee’s] Qualifying Termination (as defined below) with the Company following a Change of Control (as defined below). 
 NOW, THEREFORE, in consideration of the premises and the mutual agreements contained herein and intended to be legally bound hereby, the parties hereto agree as follows: 
 Agreement 
 1. Definitions. The following words and phrases shall
have the meanings set forth below for the purposes of this Agreement (unless the context clearly indicates otherwise): 
 (a) “Base Salary” shall mean [Executive’s/Employee’s] base salary or regular wage rate in effect immediately prior to the Qualifying Termination (not giving effect to any decrease in base salary providing
Employee with Good Reason for termination of his or her employment). Base Salary does not include variable forms of compensation such as but not limited to overtime, lead premiums, shift differentials, bonuses, incentive compensation, commissions,
expenses or expense allowances. 
 (b) “Board” shall mean the Board of Directors of Company, or any
successor thereto. 
 (c) “Cause,” as determined by the Board in good faith, shall mean Employee has:

 (1) failed to perform his or her stated duties in all material respects, which failure continues for fifteen
(15) days after [Executive’s/Employee’s] receipt of written notice of the failure from the Company; 
 (2) intentionally and materially breached any provision of this Agreement or any other written agreement with the Company, and has not cured such breach within fifteen (15) days after [Executive’s/Employee’s] receipt
of written notice of the breach from the Company (provided that, the Company’s written notice is not required if [Executive’s/Employee’s] breach is not reasonably capable of cure); 
  

 1 

 (3) demonstrated [Executive’s/Employee’s] personal dishonesty in
connection with [Executive’s/Employee’s] employment with the Company; 
 (4) engaged in willful misconduct in
connection with [Executive’s/Employee’s] employment with the Company; 
 (5) engaged in a breach of fiduciary
duty in connection with [Executive’s/Employee’s] employment with the Company; or 
 (6) willfully violated
any material law, rule or regulation, or final cease-and-desist order (other than minor traffic violations or similar offenses), been convicted or pled guilty (including a no contest plea) to any felony, or engaged in other serious misconduct of
such a nature that [Executive’s/Employee’s] continued employment may reasonably be expected to cause the Company substantial economic or reputational injury. 
 (d) “Change of Control” shall have the same definition as in the Company’s Amended and Restated 2004 Equity
Incentive Award Plan (the “2004 Equity Plan”). 
 (e) “Code” shall mean the Internal
Revenue Code of 1986, as amended. 
 (f) “Company” shall mean Medivation, Inc. or its successor, and
any corporation, partnership or other entity owned directly or indirectly, in whole or in part, by Medivation, Inc. 
 (g) “Disability” shall have the same definition as in the 2004 Equity Plan. 
 (h)
“Good Reason” shall mean: 
 (1) a material breach of this Agreement by the Company; 
 (2) the Company fails to obtain the assumption of this Agreement by any successor to Company; or 
 (3) the Company, without [Executive’s/Employee’s] express written consent: (i) materially reduces
[Executive’s/Employee’s] Base Salary or the aggregate fringe benefits provided to Employee (except to the extent the decrease is pursuant to a general compensation or benefits reduction applicable to all, or substantially all, employees of
the Company at the same position level as Employee); (ii) materially diminishes [Executive’s/Employee’s] authority, duties or responsibilities; or (iii) requires Employee to be based more than twenty-five (25) miles from
[Executive’s/Employee’s] office location as of the date of this Agreement (except for required travel on Company business to an extent substantially consistent with [Executive’s/Employee’s] business travel obligations of the date
of this Agreement). 
  

 2 

 (i) “Retirement” shall mean the termination of
[Executive’s/Employee’s] employment with the Company in accordance with the retirement policies, including early retirement policies, generally applicable to the Company’s salaried employees. 
 (j) “Qualifying Termination” shall mean the occurrence, on or within twelve (12) months following the
consummation of a Change of Control, of either (y) a termination of [Executive’s/Employee’s] employment by the Company without Cause (and for reasons other than death or Disability), or (z) a termination of
[Executive’s/Employee’s] employment by Employee for Good Reason, and in either case such termination is a “separation from service” as defined in Treasury Regulations Section 1.409A-1(h)(1)(ii). The following events shall
not constitute a Qualifying Termination: (i) Employee resigns his or her employment with the Company for any reason that does not qualify as Good Reason at any time, including but not limited to [Executive’s/Employee’s] Retirement; or
(ii) [Executive’s/Employee’s] employment is terminated for Cause, or due to death or Disability. 
 (k)
“Termination Notice” shall mean a dated notice which: (i) indicates the specific termination provision in this Agreement relied upon (if any); (ii) sets forth in reasonable detail the facts and circumstances claimed to
provide a basis for the termination of [Executive’s/Employee’s] employment under such provision; and (iii) specifies the anticipated date that termination of [Executive’s/Employee’s] employment shall become effective; and
(iv) is given in the manner specified in Section 11(j). 
 2. Term and Termination of Agreement. The term of this
Agreement shall commence on the date hereof as first written above and shall continue through December 31, 2009; provided that commencing on January 1, 2010 and each January 1st thereafter, the term of this Agreement shall
automatically be extended for one additional year unless not later than December 31 of the preceding year, the Company shall have given written notice to Employee that it does not wish to extend this Agreement. In addition, this Agreement will
terminate immediately if [Executive’s/Employee’s] employment terminates at any time (at the Company’s request or [Executive’s/Employee’s] request) if such termination is not a Qualifying Termination. 
 3. Termination of Employment. 
 (a) At-Will Employment Relationship. During the term of this Agreement, [Executive’s/Employee’s] employment relationship is at-will and both the Company and [Executive/Employee] can terminate employment at any time,
with or without advance notice, and with or without Cause. 
 (b) Termination By Company For Cause. During the
term of this Agreement, the Company shall have the right to terminate [Executive’s/Employee’s] employment for Cause by providing written notice to [Executive/Employee] specifying the particulars of the conduct of [Executive/Employee]
forming the basis for Cause to terminate [Executive’s/Employee’s] employment. The Company also must comply with any applicable advance notice and cure period requirement as specified in the definition of Cause hereunder. 
  

 3 

 (c) Termination By [Executive/Employee] For Good Reason. During the term of this
Agreement, [Executive/Employee] may terminate his or her employment for Good Reason by written notice to the Company given within sixty (60) days after the date of the occurrence of any event that [Executive/Employee] knows or should reasonably
have known constitutes Good Reason for termination. Such notice must identify [Executive/Employee] and set forth in reasonable detail the facts and circumstances claimed by [Executive/Employee] to constitute Good Reason and identify
[Executive’s/Employee’s] planned termination date (which must be at least thirty (30) days from the date that the written notice is provided to the Company). [Executive/Employee] may terminate his or her employment for Good Reason
thereafter only if the Company fails to cure the circumstances identified in [Executive’s/Employee’s] notice as giving rise to Good Reason within thirty (30) days after its receipt of [Executive’s/Employee’s] notice, and
[Executive’s/Employee’s] termination must become effective no later than sixty (60) days after the date that the Company received [Executive’s/Employee’s] notice provided hereunder. 
 4. Severance Benefits. 
 (a) Severance Benefits For Qualifying Terminations. Subject to the terms and conditions of this Agreement (including but not limited to the execution of an effective release agreement as described in Section 6 below), if
[Executive/Employee] suffers a Qualifying Termination, the Company will provide the following as [Executive’s/Employee’s] sole severance benefits (the “Severance Benefits”): 
 (i) Cash Severance Benefit. The Company shall pay in a lump sum an amount equal to [Officer/SVP: eighteen (18) months
of Executive’s][VP/SD: twelve (12) months of Employee’s] Base Salary, to be paid within ten (10) business days following the Release Effective Date (as defined in Section 6). 
 (ii) COBRA Premium Benefit. If [Executive/Employee] was enrolled in a group health plan (i.e., medical, dental, or
vision plan) sponsored by the Company immediately prior to termination, [Executive/Employee] may be eligible to continue coverage under such group health plan (or to convert to an individual policy) following his or her last day of employment under
the Consolidated Omnibus Budget Reconciliation Act of 1985 (together with any state law of similar effect, “COBRA”). If [Executive/Employee] is eligible for continued coverage under COBRA and timely elects such continued coverage,
the Company shall pay the full amount of the COBRA premiums for [Executive/Employee] and his or her eligible dependents for the first [Officer/SVP: eighteen (18)][VP/SD: twelve (12)] months of such coverage or until such earlier date as either
(A) [Executive/Employee] and/or his or her eligible dependents cease to be eligible for COBRA coverage or (B) [Executive/Employee] becomes eligible for the group health plan coverage of a subsequent employer. Following such period of
Company-paid COBRA coverage, [Executive/Employee] will be responsible for the timely payment of the full amount of premiums required under COBRA for the duration of the COBRA period (if any). [Executive/Employee] must notify the Company immediately
if he or she becomes eligible for coverage by a group health plan of a subsequent employer. 
  

 4 

 (b) Other Terminations. In the event [Executive’s/Employee’s]
employment terminates other than a Qualifying Termination, [Executive’s/Employee’s] rights upon termination shall be governed by applicable law and by the Company’s standard employment termination policy applicable to
[Executive/Employee] in effect at the time of termination or, if applicable, any written employment agreement between the Company and [Executive/Employee] other than this Agreement in effect at the time of termination. 
 (c) Certain Reductions. The Company shall reduce the Severance Benefits by any other severance benefits, pay in lieu of
notice, or other similar benefits payable to [Executive/Employee] by the Company that become payable in connection with the Qualifying Termination or termination of employment pursuant to (i) any applicable legal requirement, including, without
limitation, the Worker Adjustment and Retraining Notification Act, the California Plant Closing Act, or any other similar state law (collectively, “WARN”), (ii) a written employment or severance agreement with the Company, or
(iii) any Company policy or practice providing for severance, termination pay, or otherwise allowing [Executive/Employee] to remain on the payroll for a limited period of time after being given notice of the termination of employment. In the
Company’s sole discretion, such reductions may be applied on a retroactive basis, with severance benefits previously paid being re-characterized as payments pursuant to the Company’s statutory obligation. 
 5. Deductions and Withholdings. All payments under this Agreement will be subject to applicable withholding for federal, state and local
taxes. If [Executive/Employee] is indebted to the Company as of his or her last day of employment, the Company reserves the right to offset the Severance Benefits by the amount of such indebtedness. Additionally, if [Executive/Employee] is subject
to withholding for taxes related to any payments or benefits, including but not limited to any imputed income related to perquisites or withholding taxes due in connection with the vesting or exercise of equity awards, the Company may offset against
the Severance Benefits the amount of such withholding taxes. However, Severance Benefits payments will not be subject to any deductions for other benefit plan purposes such as 401(k) plan contributions and/or 401(k) loan repayments or other employee
benefit plan contributions. 
 6. Release of Claims. In order to be eligible to receive the Severance Benefits,
[Executive/Employee] must execute and allow to become effective a general waiver and release in substantially the form attached hereto as Exhibits A, B or C (as applicable) within the time frame set forth
therein, but in no event may such release be effective later than sixty (60) days following the date of [Executive’s/Employee’s] Qualifying Termination. The date [Executive’s/Employee’s] release agreement becomes effective,
as further described in the applicable release form, is referred to herein as the “Release Effective Date”. The Company, in its discretion, may modify the form of the required release to comply with applicable law and shall
determine the form of the required release, which may be incorporated into a termination agreement or other agreement with [Executive/Employee]. 
 7. Additional Eligibility and Transition Matters. 
 (a) Return of Company Property.
[Executive/Employee] will not be entitled to the Severance Benefits unless and until [Executive/Employee] returns all Company Property upon his or her termination (or earlier if so requested by the Company). For this purpose, “Company
Property” means all paper and electronic Company documents (and all copies thereof) created and/or received by [Executive/Employee] during his or her period of 

  

 5 

 
employment with the Company and other Company property which [Executive/Employee] had in his or her possession or control including, but not limited to,
Company files, notes, lab notebooks, drawings, records, plans, forecasts, reports, studies, analyses, proposals, agreements, financial information, research and development information, sales and marketing information, operational and personnel
information, specifications, code, software, databases, computer-recorded information, tangible property and equipment (including, but not limited to, leased vehicles, computers, computer equipment, software programs, facsimile machines, mobile
telephones, servers), credit and calling cards, entry cards, identification badges and keys; and any materials of any kind which contain or embody any proprietary or confidential information of the Company (and all reproductions thereof in whole or
in part). As a condition to receiving the Severance Benefits, [Executive/Employee] must not make or retain copies, reproductions or summaries of any such Company Property. However, [Executive/Employee] is not required to return his or her personal
copies of documents evidencing [Executive’s/Employee’s] hire, termination, compensation, benefits and stock options and any other documentation received as a shareholder of the Company. 
 (b) Prepayment of Advanced Amounts. [Executive/Employee] will not be entitled to the Severance Benefits if he or she
previously received an advance(s) for business travel and entertainment expenses unless and until [Executive/Employee] (i) properly completes and submits an expense reimbursement form(s) and supporting receipts to his or her manager no later
than the effective date of the Qualifying Termination and (ii) repays any amounts advanced but not used and approved for reimbursement. 
 (c) Transition of Work. [Executive/Employee] will not be entitled to any Severance Benefits unless and until he or she (i) has satisfactorily transitioned his or her work and information concerning his or
her work to the Company to the extent requested by the Company (including but not limited to completion of exit checklists and properly signed and witnessed lab notebooks), and (ii) has provided the Company with all logins, passwords, passcodes
and similar information created by [Executive/Employee] for documents, email and electronic files that [Executive/Employee] created or used on Company systems. 
 (d) Proprietary Information Obligations. [Executive/Employee] is not eligible for the Severance Benefits if he or she has not
signed the Company’s standard form of confidential information and inventions assignment agreement (“Proprietary Agreement”) covering [Executive’s/Employee’s] entire period of employment with the Company (and with any
predecessor) and/or if [Executive/Employee] does not confirm in writing that he or she is and shall remain subject to the terms of the Proprietary Agreement. 
 (e) Resignation From Board. If [Executive/Employee] is a member of the Board as of the Qualifying Termination, [Executive/Employee]
will not be eligible for the Severance Benefits unless he or she promptly resigns from the Board if requested to do so by a majority of the Board. 
 8. Death of [Executive/Employee]. Any amounts due [Executive/Employee] under this Agreement (not including any Base Salary not yet earned by [Executive/Employee]) unpaid as of the date of [Executive’s/Employee’s]
death shall be paid in a single sum as soon as practicable after [Executive’s/Employee’s] death to [Executive’s/Employee’s] surviving spouse, or if none, to the duly appointed personal representative of
[Executive’s/Employee’s] estate, provided that all conditions for receipt of such amounts have been satisfied. 
  

 6 

 9. Treatment of Parachute Payments. 
 (a) In the event that it shall be determined (as hereafter provided) that any payment by the Company to or for the benefit of
[Executive/Employee], whether paid or payable pursuant to the terms of this Agreement or otherwise pursuant to or by reason of any other agreement, policy, plan, program or arrangement, including without limitation any stock option, or the lapse or
termination of any restriction on or the vesting or exercisability of any of the foregoing (collectively, a “Payment”), would be subject to the excise tax imposed by Section 4999 of the Code (or any successor provision thereto)
by reason of being considered “contingent on a change in ownership or control” of the Company, within the meaning of Section 280G of the Code (or any successor provision thereto) or to any similar tax imposed by state or local law, or
any interest or penalties with respect to such tax (such tax or taxes, together with any such interest and penalties, being hereafter collectively referred to as the “Excise Tax”), then the amount of the cash Severance Benefits
payable to [Executive/Employee] hereunder shall be reduced and then the noncash payments and benefits hereunder shall be reduced, to the extent necessary so that no portion of the Payments is subject to the Excise Tax; provided, however, that
[Executive/Employee] may elect (at any time prior to the payment of any Payments under this Agreement) to have the noncash payments and benefits reduced (or eliminated) prior to any reduction of the cash payments under this Agreement.
Notwithstanding the foregoing, payments or benefits under this Agreement will not be reduced unless: (i) the net amount of the Payments, as so reduced (and after subtracting the net amount of federal, state and local income taxes on such
reduced Payments) is greater than (ii) (A) the net amount of such Payments, without reduction (but after subtracting the net amount of federal, state and local income taxes on such Payments), minus (B) the amount of Excise Tax to
which [Executive/Employee] would be subject in respect of such unreduced Payments. 
 (b) All determinations required
to be made under this Section 9, including whether an Excise Tax is payable by [Executive/Employee] and the amount of such Excise Tax, shall be made in good faith by a nationally recognized accounting firm (the “Accounting
Firm”) selected by the Company. For purposes of the computations required by this Section 9 to the extent not otherwise specified here, reasonable assumptions and approximations may be made with respect to applicable taxes and
reasonable, good faith interpretations of the Code may be relied upon and [Executive/Employee] shall be deemed to pay federal, state and local income and payroll taxes at the highest marginal rate of taxation. The Company and [Executive/Employee]
shall each provide the Accounting Firm access to and copies of any books, records and documents in the possession of the Company or [Executive/Employee], as the case may be, reasonably requested by the Accounting Firm, and otherwise cooperate with
the Accounting Firm in connection with the preparation and issuance of the determination and calculations contemplated by this Section. Any final determination by the Accounting Firm shall be binding upon the Company and [Executive/Employee]. The
Company shall pay all fees and expenses of the Accounting Firm. 
  

 7 

 10. Code Section 409A. If the Company (or, if applicable, the
successor entity thereto) determines that the Severance Benefits constitute “deferred compensation” under Section 409A of the Code (Section 409A, together, with any state law of similar effect, “Section 409A”) and
[Executive/Employee] is, at the time of the separation from service, a “specified employee” of the Company (or any successor entity thereto), as such term is defined in Section 409A(a)(2)(B)(i) (a “Specified
Employee”), then, solely to the extent necessary to avoid the incurrence of the adverse personal tax consequences under Section 409A, the timing of the Severance Benefits shall be delayed as follows: on the earlier to occur of
(i) the date that is six months and one day after [Executive’s/Employee’s] separation from service and (ii) the date of [Executive’s/Employee’s] death (such earlier date, the “Delayed Initial Payment
Date”), the Company (or the successor entity thereto, as applicable) shall (A) pay to [Executive/Employee] a lump sum amount equal to the sum of the Severance Benefits that [Executive/Employee] would otherwise have received through the
Delayed Initial Payment Date if the commencement of the payment of the Severance Benefits had not been delayed pursuant to this Section 10 and (B) commence paying the balance of the Severance Benefits in accordance with the original
payment schedules set forth above. For the avoidance of doubt, it is intended that (1) each installment of the Severance Benefits is a separate “payment” for purposes of Section 409A, (2) all Severance Benefits satisfy, to
the greatest extent possible, the exemptions from the application of Section 409A provided under of Treasury Regulations Sections 1.409A-1(b)(4), 1.409A-1(b)(5) and 1.409A-1(b)(9)(iii), and (3) the Severance Benefits consisting of premiums
paid under COBRA also satisfy, to the greatest extent possible, the exemptions from the application of Section 409A provided under Treasury Regulation Section 1.409A-1(b)(9)(v). 
 11. Miscellaneous. 
 (a) Amendment. No provision of this Agreement may be amended unless such amendment is signed by [Executive/Employee] and such officer as may be specifically designated by the Board to sign on the Company’s behalf.

 (b) Transfer and Assignment. The rights and obligations of [Executive/Employee] under this Agreement may not
be transferred or assigned without the prior written consent of the Company. This Agreement shall be binding upon any person who is a successor by merger, acquisition, consolidation or otherwise to the business formerly carried on by the Company
without regard to whether or not such person or entity actively assumes the obligations hereunder. 
 (c)
Counterparts. This Agreement and any amendment or supplement to this Agreement may be executed in two or more counterparts, each of which will constitute an original but all of which will together constitute a single instrument. Transmission
by facsimile or PDF of an executed counterpart signature page hereof by a party hereto shall constitute due execution and delivery of this Agreement by such party. 
 (d) Nature of Obligations. Nothing contained herein shall create or require the Company to create a trust of any kind to
fund any benefits which may be payable hereunder, and to the extent that [Executive/Employee] acquires a right to receive benefits from the Company hereunder, such right shall be no greater than the right of any unsecured general creditor of the
Company. 
  

 8 

 (e) ERISA. For purposes of the Employee Retirement Income Security Act of
1974, this Agreement is intended to be a severance pay employee welfare benefit plan, and not an employee pension plan, and shall be construed and administered with that intention. 
 (f) Prior Employment. [Executive/Employee] represents and warrants that acceptance of employment with the Company has not breached,
and the performance of his or her employment duties to the Company will not breach, any duty owed by [Executive/Employee] to any prior employer or other person. 
 (g) Headings. The Section headings contained in this Agreement are for reference purposes only and shall not affect in any way the
meaning or interpretation of this Agreement. In the event of a conflict between a heading and the content of a Section, the content of the Section shall control. 
 (h) Severability. If any provision of this Agreement or the application thereof to any person or circumstance shall be invalid or
unenforceable under any applicable law, such event shall not affect or render invalid or unenforceable any other provision of this Agreement and shall not affect the application of any provision to other persons or circumstances, and, if possible,
the invalid or unenforceable provision shall be modified to become valid and enforceable to the greatest extent consistent with the general intent of the parties hereunder. 
 (i) Binding Effect. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective
successors, permitted assigns, heirs, executors and administrators. 
 (j) Notices. For purposes of this Agreement,
notices and all other communications provided for in this Agreement shall be in writing and shall be deemed to have been duly given (A) on the delivery date if hand-delivered or sent by facsimile transmittal, (B) on the following business
day if sent by documented overnight delivery service, and (C) within five (5) business days if sent by certified or registered mail, return receipt requested, postage prepaid, in each case addressed to the respective addresses set forth
below or any other address as may be designated in writing by the affected party: 
 To the Company: 
 Medivation, Inc. 
 201 Spear Street, 3rd Floor

 San Francisco, CA 94105 
 Attention: Chief Financial Officer 
 To [Executive/Employee]: 
 _____________________________________ 
 _____________________________________ 
 _____________________________________ 
  

 9 

 (k) Entire Agreement. This Agreement sets forth the entire understanding of
the parties and supersedes all prior agreements, arrangements and communications, whether oral or written, pertaining to the subject matter of hereof. This Agreement provides the exclusive benefits that [Executive/Employee] may become eligible to
receive upon a Qualifying Termination, and shall supersede any other severance plan, policy or practice, whether formal or informal, written or unwritten, previously announced or maintained by the Company (with the exception of any provisions
contained in any equity incentive plan or award agreement providing for accelerated vesting of option shares upon or following a Qualifying Termination). 
 (l) No Implied Employment Contract. This Agreement shall not be deemed (i) to give [Executive/Employee] or any other person any right to be retained in the employ of the Company or (ii) to
interfere with the right of the Company to discharge [Executive/Employee] or any other person at any time, with or without cause, which right is hereby reserved. 
 (m) Waiver. Any party’s failure to enforce any provision or provisions of this Agreement shall not in any way be
construed as a waiver of any such provision or provisions, nor prevent any party from thereafter enforcing each and every other provision of this Agreement. The rights granted the parties herein are cumulative and shall not constitute a waiver of
any party’s right to assert all other legal remedies available to it under the circumstances. 
 (n) Circular
230 Disclaimer. The following disclaimer is provided in accordance with the Internal Revenue Service’s Circular 230 (21 CFR Part 10). Any advice in this Agreement is not intended or written to be used, and it cannot be used, by
[Executive/Employee] for the purpose of avoiding any penalties that may be imposed on [Executive/Employee]. Any advice in this Agreement was written to support the promotion or marketing of participation in the Company’s change of control
severance benefit program. [Executive/Employee] should seek advice based on his or her particular circumstances from an independent tax advisor. 
 (o) Governing Law. The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the United States where applicable and otherwise by the laws of the State
of California without regard to conflict of laws principles. 
 IN WITNESS WHEREOF, this Agreement has been executed as of the date first
above written. 
  

									
	MEDIVATION, INC.	 		 	[Executive/Employee]
				
	By:	 	 	 		 	 
	Its:	 	President and Chief Executive Officer	 		 		 	

  

 10 

					
	Exhibit A	 	–	 	Release Agreement For Employees 40 Or Older (Group Termination)
			
	Exhibit B	 	–	 	Release Agreement For Employees 40 Or Older (Individual Termination)
			
	Exhibit C	 	–	 	Release Agreement For Employees Under 40 Years Old (Individual or Group Termination)

  

 11 

 EXHIBIT A 
 RELEASE AGREEMENT FOR EMPLOYEES 40 OR OLDER 
 (GROUP TERMINATION)

 As provided in the CHANGE OF CONTROL SEVERANCE BENEFITS
AGREEMENT dated             , 2009 (the “Agreement”) between me and Medivation, Inc. (the “Company”), I will be
eligible for certain severance benefits related to a Qualifying Termination following a Change of Control if I enter into this Release Agreement (the “Release”). I am not relying on any promise or representation by the Company that
is not expressly stated in the Agreement. Certain capitalized terms used in this Release are defined in the Agreement. 
 I hereby
acknowledge and reaffirm my obligations under my Proprietary Agreement with the Company. 
 In consideration of the Severance Benefits, and
other consideration, provided to me under the Agreement that I am not otherwise entitled to receive, and except as otherwise set forth in this Release, I hereby generally and completely release the Company and its current and former directors,
officers, employees, stockholders, shareholders, partners, agents, attorneys, predecessors, successors, parent and subsidiary entities, insurers, affiliates, and assigns (collectively, the “Released Parties”) from any and all
claims, liabilities and obligations, both known and unknown, that arise out of or are in any way related to events, acts, conduct, or omissions occurring prior to my signing this Release (collectively, the “Released Claims”). The
Released Claims include, but are not limited to: (1) all claims arising out of or in any way related to my employment with the Company or its affiliates, or the termination of that employment; (2) all claims related to my compensation or
benefits, including salary, bonuses, commissions, vacation pay, expense reimbursements, severance pay, fringe benefits, stock, stock options, or any other ownership interests in the Company or its affiliates; (3) all claims for breach of
contract, wrongful termination, and breach of the implied covenant of good faith and fair dealing; (4) all tort claims, including claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (5) all
federal, state, and local statutory claims, including claims for discrimination, harassment, retaliation, attorneys’ fees, or other claims arising under the federal Civil Rights Act of 1964 (as amended), the federal Americans with Disabilities
Act of 1990, the federal Age Discrimination in Employment Act of 1967 (as amended) (“ADEA”), the federal Employee Retirement Income Security Act of 1974 (as amended), and the California Fair Employment and Housing Act (as amended).

 Notwithstanding the foregoing, the following are not included in the Released Claims (the “Excluded Claims”):
(1) any rights or claims for indemnification I may have pursuant to any written indemnification agreement with the Company to which I am a party, the charter, bylaws, or operating agreements of the Company, or under applicable law; or
(2) any rights which are not waivable as a matter of law. In addition, nothing in this Release prevents me from filing, cooperating with, or participating in any proceeding before the Equal Employment Opportunity Commission, the Department of
Labor, the California Department of Fair Employment and Housing, or any other government agency, except that I hereby waive my right 

  

 A-1 

 
to any monetary benefits in connection with any such claim, charge or proceeding. I hereby represent and warrant that, other than the Excluded Claims, I am
not aware of any claims I have or might have against any of the Released Parties that are not included in the Released Claims. 
 I
acknowledge that I am knowingly and voluntarily waiving and releasing any rights I may have under the ADEA. I also acknowledge that the consideration given for the Released Claims is in addition to anything of value to which I was already entitled.
I further acknowledge that I have been advised by this writing, as required by the ADEA, that: (1) the Released Claims do not apply to any rights or claims that arise after the date I sign this Release; (2) I should consult with an
attorney prior to signing this Release (although I may choose voluntarily not to do so); (3) I have forty-five (45) days to consider this Release (although I may choose to voluntarily sign it sooner); (4) I have seven (7) days
following the date I sign this Release to revoke the Release by providing written notice to the Chief Employee Officer of the Company; and (5) the Release will not be effective until the date upon which the revocation period has expired
unexercised, which will be the eighth day after I sign this Release (the “Release Effective Date”). 
 I have received with
this Release all of the information required by the ADEA, including without limitation a detailed list of the job titles and ages of all employees who were terminated in this group termination and the ages of all employees of the Company in the same
job classification or organizational unit who were not terminated, along with information on the eligibility factors used to select employees for the group termination and any time limits applicable to this group termination program. 
 I acknowledge that I have read and understand Section 1542 of the California Civil Code which reads as follows: “A general release does not
extend to claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which if known by him or her must have materially affected his or her settlement with the debtor.” I hereby
expressly waive and relinquish all rights and benefits under that section and any law of any jurisdiction of similar effect with respect to my release of any claims I may have against the Company. 
 I hereby represent that I have been paid all compensation owed and for all hours worked, I have received all the leave and leave benefits and protections
for which I am eligible, and I have not suffered any on-the-job injury for which I have not already filed a workers’ compensation claim. 
 I hereby agree not to disparage the Company, or its officers, directors, employees, shareholders or agents, in any manner likely to be harmful to its or their business, business reputation, or personal reputation; provided, however,
that I will respond accurately and fully to any question, inquiry or request for information when required by legal process. 
  

 A-2 

 I acknowledge that to become effective, I must: (1) sign and return this Release to the Company
within forty-five (45) days after I am requested to sign it by the Company or its successor (as applicable); and (2) I must not revoke it thereafter. 
  

			
	[EXECUTIVE/EMPLOYEE]
	
	 
		
	Printed Name:	 	 
		
	Date:	 	 

  

 A-3 

 EXHIBIT B 
 RELEASE AGREEMENT FOR EMPLOYEES 40 OR OLDER 
 (INDIVIDUAL TERMINATION) 

 As provided in the CHANGE OF CONTROL SEVERANCE BENEFITS
AGREEMENT dated             , 2009 (the “Agreement”) between me and Medivation, Inc. (the “Company”), I will be
eligible for certain severance benefits related to a Qualifying Termination following a Change of Control if I enter into this Release Agreement (the “Release”). I am not relying on any promise or representation by the Company that
is not expressly stated in the Agreement. Certain capitalized terms used in this Release are defined in the Agreement. 
 I hereby
acknowledge and reaffirm my obligations under my Proprietary Agreement with the Company. 
 In consideration of the Severance Benefits, and
other consideration, provided to me under the Agreement that I am not otherwise entitled to receive, and except as otherwise set forth in this Release, I hereby generally and completely release the Company and its current and former directors,
officers, employees, stockholders, shareholders, partners, agents, attorneys, predecessors, successors, parent and subsidiary entities, insurers, affiliates, and assigns (collectively, the “Released Parties”) from any and all
claims, liabilities and obligations, both known and unknown, that arise out of or are in any way related to events, acts, conduct, or omissions occurring prior to my signing this Release (collectively, the “Released Claims”). The
Released Claims include, but are not limited to: (1) all claims arising out of or in any way related to my employment with the Company or its affiliates, or the termination of that employment; (2) all claims related to my compensation or
benefits, including salary, bonuses, commissions, vacation pay, expense reimbursements, severance pay, fringe benefits, stock, stock options, or any other ownership interests in the Company or its affiliates; (3) all claims for breach of
contract, wrongful termination, and breach of the implied covenant of good faith and fair dealing; (4) all tort claims, including claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (5) all
federal, state, and local statutory claims, including claims for discrimination, harassment, retaliation, attorneys’ fees, or other claims arising under the federal Civil Rights Act of 1964 (as amended), the federal Americans with Disabilities
Act of 1990, the federal Age Discrimination in Employment Act of 1967 (as amended) (“ADEA”), the federal Employee Retirement Income Security Act of 1974 (as amended), and the California Fair Employment and Housing Act (as amended).

 Notwithstanding the foregoing, the following are not included in the Released Claims (the “Excluded Claims”):
(1) any rights or claims for indemnification I may have pursuant to any written indemnification agreement with the Company to which I am a party, the charter, bylaws, or operating agreements of the Company, or under applicable law; or
(2) any rights which are not waivable as a matter of law. In addition, nothing in this Release prevents me from filing, cooperating with, or participating in any proceeding before the Equal Employment Opportunity Commission, the Department of
Labor, the California Department of Fair Employment and Housing, or any other government agency, except that I hereby waive my right to any monetary benefits in connection with any such claim, charge or proceeding. I hereby represent and warrant
that, other than the Excluded Claims, I am not aware of any claims I have or might have against any of the Released Parties that are not included in the Released Claims. 
  

 B-1 

 I acknowledge that I am knowingly and voluntarily waiving and releasing any rights I may have under the
ADEA. I also acknowledge that the consideration given for the Released Claims is in addition to anything of value to which I was already entitled. I further acknowledge that I have been advised by this writing, as required by the ADEA, that:
(1) the Released Claims do not apply to any rights or claims that arise after the date I sign this Release; (2) I should consult with an attorney prior to signing this Release (although I may choose voluntarily not to do so); (3) I
have twenty-one (21) days to consider this Release (although I may choose to voluntarily sign it sooner); (4) I have seven (7) days following the date I sign this Release to revoke the Release by providing written notice to the Chief
Executive Officer of the Company; and (5) the Release will not be effective until the date upon which the revocation period has expired unexercised, which will be the eighth day after I sign this Release (the “Release Effective
Date”). 
 I acknowledge that I have read and understand Section 1542 of the California Civil Code which reads as follows:
“A general release does not extend to claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which if known by him or her must have materially affected his or her settlement with
the debtor.” I hereby expressly waive and relinquish all rights and benefits under that section and any law of any jurisdiction of similar effect with respect to my release of any claims I may have against the Company. 
 I hereby represent that I have been paid all compensation owed and for all hours worked, I have received all the leave and leave benefits and protections
for which I am eligible, and I have not suffered any on-the-job injury for which I have not already filed a workers’ compensation claim. 
 I hereby agree not to disparage the Company, or its officers, directors, employees, shareholders or agents, in any manner likely to be harmful to its or their business, business reputation, or personal reputation; provided, however,
that I will respond accurately and fully to any question, inquiry or request for information when required by legal process. 
  

 B-2 

 I acknowledge that to become effective, I must: (1) sign and return this Release to the Company
within twenty-one (21) days after I am requested to sign it by the Company or its successor (as applicable); and (2) I must not revoke it thereafter. 
  

			
	[EXECUTIVE/EMPLOYEE]
	
	 
		
	Printed Name:	 	 
		
	Date:	 	 

  

 B-3 

 EXHIBIT C 
 RELEASE AGREEMENT FOR EMPLOYEES UNDER 40 YEARS OLD 
 (INDIVIDUAL OR GROUP
TERMINATION) 
 As provided in the CHANGE OF CONTROL SEVERANCE
BENEFITS AGREEMENT dated             , 2009 (the “Agreement”) between me and Medivation, Inc. (the
“Company”), I will be eligible for certain severance benefits related to a Qualifying Termination following a Change of Control if I enter into this Release Agreement (the “Release”). I am not relying on any promise
or representation by the Company that is not expressly stated in the Agreement. Certain capitalized terms used in this Release are defined in the Agreement. 
 I hereby acknowledge and reaffirm my obligations under my Proprietary Agreement with the Company. 
 In
consideration of the Severance Benefits, and other consideration, provided to me under the Agreement that I am not otherwise entitled to receive, and except as otherwise set forth in this Release, I hereby generally and completely release the
Company and its current and former directors, officers, employees, stockholders, shareholders, partners, agents, attorneys, predecessors, successors, parent and subsidiary entities, insurers, affiliates, and assigns (collectively, the
“Released Parties”) from any and all claims, liabilities and obligations, both known and unknown, that arise out of or are in any way related to events, acts, conduct, or omissions occurring prior to my signing this Release
(collectively, the “Released Claims”). The Released Claims include, but are not limited to: (1) all claims arising out of or in any way related to my employment with the Company or its affiliates, or the termination of that
employment; (2) all claims related to my compensation or benefits, including salary, bonuses, commissions, vacation pay, expense reimbursements, severance pay, fringe benefits, stock, stock options, or any other ownership interests in the
Company or its affiliates; (3) all claims for breach of contract, wrongful termination, and breach of the implied covenant of good faith and fair dealing; (4) all tort claims, including claims for fraud, defamation, emotional distress, and
discharge in violation of public policy; and (5) all federal, state, and local statutory claims, including claims for discrimination, harassment, retaliation, attorneys’ fees, or other claims arising under the federal Civil Rights Act of
1964 (as amended), the federal Americans with Disabilities Act of 1990, the federal Employee Retirement Income Security Act of 1974 (as amended), and the California Fair Employment and Housing Act (as amended). 
 Notwithstanding the foregoing, the following are not included in the Released Claims (the “Excluded Claims”): (1) any rights or
claims for indemnification I may have pursuant to any written indemnification agreement with the Company to which I am a party, the charter, bylaws, or operating agreements of the Company, or under applicable law; or (2) any rights which are
not waivable as a matter of law. In addition, nothing in this Release prevents me from filing, cooperating with, or participating in any proceeding before the Equal Employment Opportunity Commission, the Department of Labor, the California
Department of Fair Employment and Housing, or any other government agency, except that I hereby waive my right 

  

 C-1 

 
to any monetary benefits in connection with any such claim, charge or proceeding. I hereby represent and warrant that, other than the Excluded Claims, I am
not aware of any claims I have or might have against any of the Released Parties that are not included in the Released Claims. 
 This
Release will be effective as of the first business day that I return the signed Release to the Company (the “Release Effective Date”). 
 I acknowledge that I have read and understand Section 1542 of the California Civil Code which reads as follows: “A general release does not extend to claims which the creditor does not know or suspect to
exist in his or her favor at the time of executing the release, which if known by him or her must have materially affected his or her settlement with the debtor.” I hereby expressly waive and relinquish all rights and benefits under that
section and any law of any jurisdiction of similar effect with respect to my release of any claims I may have against the Company. 
 I
hereby represent that I have been paid all compensation owed and for all hours worked, I have received all the leave and leave benefits and protections for which I am eligible, and I have not suffered any on-the-job injury for which I have not
already filed a workers’ compensation claim. 
 I hereby agree not to disparage the Company, or its officers, directors, employees,
shareholders or agents, in any manner likely to be harmful to its or their business, business reputation, or personal reputation; provided, however, that I will respond accurately and fully to any question, inquiry or request for information
when required by legal process. 
 I acknowledge that to become effective, I must sign and return this Release to the Company within
fourteen (14) days after I am requested to sign it by the Company or its successor (as applicable). 
  

			
	[EXECUTIVE/EMPLOYEE]
	
	 
		
	Printed Name:	 	 
		
	Date:	 	 

  

 C-2Form of Restricted Stock Unit Agreement

 EXHIBIT 10.5.1 
 ICAGEN, INC. 
 2004 STOCK INCENTIVE PLAN 
 RESTRICTED STOCK UNIT AGREEMENT 
 This RESTRICTED STOCK UNIT AGREEMENT (the
“Agreement”), dated as of              (the “Date of Grant”), is delivered by Icagen, Inc., a Delaware corporation (“Icagen”), to
             (the “Grantee”), a director of Icagen. 
 RECITALS 
 The Icagen, Inc. 2004 Stock Incentive Plan (the “Plan”) provides for the grant of stock-based awards
with respect to shares of common stock, par value $0.001 per share, of Icagen (the “Common Stock”), in accordance with the terms and conditions of the Plan. The Board of Directors of Icagen (the “Board’), upon recommendation of
the Compensation Committee of the Board (the “Committee”), has determined to make a stock-based award in the form of a grant of restricted stock units, subject to the terms and conditions set forth in this Agreement and the Plan. The
Grantee may obtain a copy of the Plan by contacting the Human Resources Manager at Icagen. 
 NOW, THEREFORE, the parties to this Agreement,
intending to be legally bound hereby, agree as follows: 
 1. Grant of Restricted Stock Units. Subject to the terms and conditions set forth in this
Agreement and the Plan and as of the Date of Grant, Icagen hereby grants to the Grantee                      restricted stock units (the
“Restricted Stock Units”) under the Plan. The Grantee accepts the Restricted Stock Units and agrees to be bound by the terms and conditions of this Agreement and the Plan with respect to the Restricted Stock Units. 
 2. Restricted Unit Account. The Restricted Stock Units represent the right to receive shares of Common Stock, subject to the vesting and other terms and conditions
of this Agreement, and are not actual shares of stock. Icagen shall establish and maintain a Restricted Stock Unit account, as a bookkeeping account on its records, for the Grantee and shall record in such account the number of Restricted Stock
Units granted to the Grantee. No shares of stock shall be issued to the Grantee at the time the grant is made, and the Grantee shall not be, nor have any of the rights or privileges of, a stockholder of Icagen with respect to any Restricted Stock
Units recorded in the account. The Grantee shall not have the right to receive any dividends or other distributions with respect to Restricted Stock Units recorded in the Grantee’s account; provided, however, that the Committee may
appropriately adjust the number and kind of Restricted Stock Units in the event of a stock split, stock dividend or other change in capitalization of Icagen, as provided in the Plan. The Grantee shall not have any interest in any fund or specific
assets of Icagen by reason of this award or the Restricted Unit account established for the Grantee. 

 3. Vesting of Restricted Stock Units. 
 The Restricted Stock Units shall vest in full on December 31, 2009 (the “Vesting Date”), provided that the Grantee does not cease to serve
as a member of the Board prior to the Vesting Date. Notwithstanding the foregoing, upon a Change of Control Event, as defined in the Plan, the Restricted Stock Units shall automatically become fully vested effective immediately prior to the
consummation of such Change of Control Event. In the event of a Reorganization Event (as defined in the Plan) that is not a Change of Control Event, the provisions set forth in Section 8(c)(3)(a) of the Plan shall apply to the Restricted Stock
Units. 
 4. Issuance of Common Stock. 
 (a) When the Restricted Stock Units vest as described above, such Restricted Stock Units shall no
longer be subject to forfeiture. Subject to the terms of this Agreement, Icagen shall issue or cause to be issued to the Grantee one share of Common Stock for each whole vested Restricted Stock Unit on, or as soon as practicable after, the date the
Restricted Stock Units vest in accordance with Paragraph 3 (but in any event by the thirtieth (30th) day following such date), subject to the
satisfaction of the Grantee’s tax withholding obligations as described below. 
 (b) All obligations of Icagen and rights of Grantee
under this Agreement shall be subject to the rights of Icagen as set forth in the Plan to withhold any amounts that may be required to be withheld by Icagen for applicable taxes. In the event Icagen determines it has tax withholding obligations with
respect to the Restricted Stock Units, the Grantee agrees to arrange for the satisfaction of the minimum amount of such tax withholding obligations in a manner acceptable to Icagen as a condition to the issuance of the shares of Common Stock under
Paragraph 4(a). 
 (c) The obligation of Icagen to deliver shares hereunder shall also be subject to the condition that if at any time the
Committee shall determine in its discretion that the listing, registration or qualification of the shares of Common Stock upon any securities exchange or under any state or federal law, or the consent or approval of any governmental regulatory body,
is necessary or desirable as a condition of, or in connection with, the issue of shares, the shares may not be issued in whole or in part unless such listing, registration, qualification, consent or approval shall have been effected or obtained free
of any conditions not acceptable to the Committee. The issuance of shares of Common Stock to the Grantee pursuant to this Agreement is subject to any applicable taxes and other laws or regulations of the United States or of any state having
jurisdiction thereof. 
 (d) The Grantee agrees to be bound by Icagen’s policies regarding transfer of shares of Common Stock and
understands that there may be certain times during the year in which the Grantee will be prohibited from selling, transferring, pledging, donating, assigning, mortgaging, hypothocating or encumbering shares. 
 5. Termination of Restricted Stock Units. If the Grantee ceases to serve as a member of the Board prior to the Vesting Date for any reason, the Restricted Stock
Units shall automatically terminate and shall be forfeited as of the date the Grantee ceases to serve as a director. No payment or issuance of Common Stock shall be made with respect to any Restricted Stock Units that terminate as described in this
Paragraph 5. 
  

 2 

 6. Grant Subject to Plan Provisions. This grant is made pursuant to the Plan, the terms of which are incorporated
herein by reference, and in all respects shall be interpreted in accordance with the Plan. The grant and payment of the Restricted Stock Units are subject to interpretations, regulations and determinations concerning the Plan established from time
to time by the Committee in accordance with the provisions of the Plan, including, but not limited to, provisions pertaining to (i) rights and obligations with respect to withholding taxes, (ii) the registration, qualification or listing
of the shares issued under the Plan, (iii) changes in capitalization of Icagen, and (iv) other requirements of applicable law. The Committee shall have the authority to interpret and construe the Restricted Stock Units pursuant to the
terms of the Plan, and its decisions shall be conclusive as to any questions arising hereunder. 
 7. No Right to Continued Board Service. The grant
of the Restricted Stock Units shall not confer upon the Grantee any right to continued service as a director of the Company. 
 8. No Stockholder
Rights. Neither the Grantee, nor any person entitled to receive payment in the event of the Grantee’s death, shall have any of the rights and privileges of a stockholder with respect to shares of Common Stock, until certificates for shares
have been issued upon payment of Restricted Stock Units. 
 9. Assignment and Transfers. Except as the Committee may otherwise permit pursuant to the
Plan, the rights and interests of the Grantee under this Agreement may not be sold, assigned, encumbered or otherwise transferred except, in the event of the death of the Grantee, by will or by the laws of descent and distribution. In the event of
any attempt by the Grantee to alienate, assign, pledge, hypothecate, or otherwise dispose of the Restricted Stock Units or any right hereunder, except as provided for in this Agreement, or in the event of the levy or any attachment, execution or
similar process upon the rights or interests hereby conferred, Icagen may terminate the Restricted Stock Units by notice to the Grantee, and the Restricted Stock Units and all rights hereunder shall thereupon become null and void. The rights and
protections of Icagen hereunder shall extend to any successors or assigns of Icagen, and to Icagen’s parents, subsidiaries, and affiliates, as applicable. This Agreement may be assigned by Icagen without the Grantee’s consent. 

10. Agreement in Connection with Public Offering. The Grantee agrees, in connection with an underwritten public offering of Icagen’s securities pursuant
to a registration statement under the Securities Act of 1933, as amended, (i) not to sell, make short sale of, loan, grant any options for the purchase of, or otherwise dispose of any shares of Common Stock held by the Grantee (other than those
shares included in the offering) without the prior written consent of Icagen or the underwriters managing such underwritten public offering of Icagen’s securities for such number of days (not to exceed 180 days) from the effective date of such
registration statement as the managing underwriters or Icagen may require, and (ii) to execute any agreement reflecting clause (i) above as may be requested by Icagen or the managing underwriters at the time of such offering. 

 

 3 

 11. Unfunded Arrangement. The Grantee’s rights to receive payments under this Agreement shall be no greater
than the right of an unsecured general creditor of Icagen. All payments shall be made from the general assets of Icagen, and no special or separate fund shall be established and no segregation of assets shall be made to assure payment. 

12. Tax Consequences. The Grantee acknowledges that the Grantee may be subject to adverse tax consequences as a result of the issuance, vesting and/or
distribution of the Restricted Stock Units and/or the Common Stock and understands that the Grantee should consult a tax advisor as to the tax consequences of the Restricted Stock Units and subsequent distribution of Common Stock. To the extent that
this Agreement, the issuance and vesting of the Restricted Stock Units and/or distribution of Common Stock as set forth in this Agreement is subject to Section 409A of the Internal Revenue Code of 1986, as amended, and any regulations
promulgated thereunder (the “Code”), the Grantee agrees to cooperate and work together with Icagen to timely amend this Grant to comply with Section 409A of the Code as necessary. 
 13. Applicable Law. The validity, construction, interpretation and effect of this Agreement shall be governed by and construed in accordance with the laws of the
State of Delaware, without giving effect to the conflicts of laws provisions thereof. 
 14. Notice. Any notice to Icagen provided for in this
Agreement shall be addressed to Icagen, Inc. in care of the Human Resources Manager, at the corporate headquarters of Icagen, and any notice to the Grantee shall be addressed to such Grantee at the current address shown on the payroll of Icagen, or
to such other address as the Grantee may designate to Icagen, in writing. Any notice shall be delivered by hand, sent by telecopy or enclosed in a properly sealed envelope addressed as stated above, registered and deposited, postage prepaid, in a
post office regularly maintained by the United States Postal Service. 
  

 4 

 IN WITNESS WHEREOF, Icagen has caused its duly authorized officer to execute this Restricted Stock Unit
Agreement, and the Grantee has placed his signature hereon, effective as of the Date of Grant. 
  

			
	ICAGEN, INC.
		
	 By: 
	 	  

	 Name:
	 	
	 Title:
	 	

 ACCEPTANCE: 
 I
hereby accept the award of Restricted Stock Units described in this Agreement, and I agree to be bound by the terms of the Plan and this Agreement. I hereby agree that all of the decisions and determinations of the Committee with respect to the
Restricted Stock Units shall be final and binding. 
  

	
	  

	 Grantee

	
	  

	 Date

  

 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00155-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00155-of-00352.parquet"}]]